Proteasome Inhibitors Enhance Gene Delivery by AAV Virus Vectors Expressing Large Genomes in Hemophilia Mouse and Dog Models: A Strategy for Broad Clinical Application
Open Access
- 1 November 2010
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 18 (11), 1907-1916
- https://doi.org/10.1038/mt.2010.170
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Little Vector, Big Gene Transduction: Fragmented Genome Reassembly of Adeno-associated VirusMolecular Therapy, 2010
- Characterization of Genome Integrity for Oversized Recombinant AAV VectorMolecular Therapy, 2010
- Proteasome Inhibitors Decrease AAV2 Capsid derived Peptide Epitope Presentation on MHC Class I Following TransductionMolecular Therapy, 2010
- Evidence for the Failure of Adeno-associated Virus Serotype 5 to Package a Viral Genome ≥8.2 kbMolecular Therapy, 2010
- Effect of Genome Size on AAV Vector PackagingMolecular Therapy, 2010
- Transient Pretreatment With Glucocorticoid Ablates Innate Toxicity of Systemically Delivered Adenoviral Vectors Without Reducing EfficacyMolecular Therapy, 2009
- Enhanced Factor VIII Heavy Chain for Gene Therapy of Hemophilia AMolecular Therapy, 2009
- Tyrosine-phosphorylation of AAV2 vectors and its consequences on viral intracellular trafficking and transgene expressionVirology, 2008
- Enhancing transduction of the liver by adeno-associated viral vectorsGene Therapy, 2008
- The Enhancing Effects of the Light Chain on Heavy Chain Secretion in Split Delivery of Factor VIII GeneMolecular Therapy, 2007